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DESCRIPTION of CASE
A 
72-year-old woman was admitted with progressive 
lower limb weakness, such that she was unable to 
stand or walk. She was previously healthy, accustomed 
to play tennis twice a week. Five days prior to admission she 
had developed low back pain radiating to the legs without a 
history of trauma. The pain was followed by numbness in the 
legs, beginning distally and then ascending over two or three 
days. The patient also experienced weakness that became 
progressively worse, initially making it difficult to climb stairs 
and then to walk and stand. Although she had no difficulty 
passing urine, she did complain of impaired sensation of 
bladder filling. She had noted some difficulty picking up 
objects with her hands but had no complaint of upper limb 
numbness or weakness at the time of admission.
Eighteen months earlier she had been diagnosed with 
diabetes mellitus, which was controlled with diet and an oral 
hypoglycaemic agent. There was a long-standing history of 
hypertension controlled with valsartan and felodipine. There 
was no recent history of travel overseas. No similar clinical 
problems were known in close family or friends.
General medical examination at the time of admission was 
unremarkable, aside from a palpable bladder, and she was 
apyrexial. Examination of the nervous system showed the 
cranial nerves to be intact. Upper limbs were normal in tone, 
but the lower limbs were flaccid. Weakness was evident, the 
pattern being more severe in the legs with greater distal than 
proximal involvement. Medical Research Council muscle power 
grade (out of 5) was 2 distally, 3–4 proximally in the arms 
and 1 distally, 2 proximally in the legs. Tendon reflexes were 
absent throughout. Sensory examination showed reduction in 
pin-prick sensation to the knees and vibration sensation to the 
costal margins, and impaired distal proprioception.
What Is the Differential Diagnosis?
The patient had an acute evolving neurological syndrome 
with largely symmetrical sensorimotor dysfunction, with 
greater motor involvement causing an areflexic flaccid 
quadriparesis, the temporal and spatial pattern of which was 
ascending from lower to upper and from distal to proximal 
in the limbs. The differential diagnosis of this picture is 
potentially broad (Box 1), encompassing myelopathies, 
polyneuropathies, neuromuscular transmission disorders, and 
myopathies, although many of these possibilities are rapidly 
excluded on the basis of the clinical features. 
An acute myelopathy such as cord compression or 
transverse myelitis may present with quadriparesis with, at 
least in the acute phase, hypotonia and depressed reflexes 
(i.e., a lower motor neuron pattern of signs). More typically, 
spasticity and hyperreflexia with extensor plantar responses 
(i.e., upper motor neuron signs) with a sensory level and 
prominent sphincter involvement would be expected, 
especially with evolution over time. Bickerstaff brainstem 
encephalitis often has extensive cranial nerve involvement out 
of proportion to accompanying quadriparesis.
Acute polyneuropathies have a broad differential diagnosis 
(Box 2). They may be classified as primary, the Guillain-
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Box 1: Differential Diagnosis of Acute Evolving 
Flaccid Quadriparesis
Myelopathies:
sÈ #OMPRESSIVEÈMYELOPATHY
sÈ 4RANSVERSEÈMYELITISÈBRAINSTEMÈENCEPHALITIS
sÈ .ECROTISINGÈMYELOPATHY
sÈ )NFECTIONÈPOLIOMYELITISÈENTEROVIRUSÈFLAVIVIRUSES
Neuropathies: see Box 2
Neuromuscular junction transmission disorder:
sÈ -YASTHENIAÈGRAVIS
sÈ ,AMBERT
%ATONÈMYASTHENICÈSYNDROME
sÈ "OTULISM
sÈ 6ENOMÈSNAKEÈSEAÈURCHIN
Myopathies:
sÈ !CUTEÈINFLAMMATORYÈMYOPATHIES
Others:
sÈ #ONVERSIONÈDISORDERFACTITIOUSÈDISORDER
sÈ "RAINSTEMÈINFARCTIONÈLOCKED
INÈSYNDROME	PLoS Medicine  |  www.plosmedicine.org 1212 August 2008  |  Volume 5  |  Issue 8  |  e180
Barré group of disorders, or secondary, for example to 
metabolic disorders (e.g., diabetes, porphyria), infectious 
disease (e.g., AIDS, Lyme disease, hepatitis C), drugs and 
toxins (e.g., alcohol, vincristine, pyridoxine), or autoimmune 
and malignant disorders (e.g., connective tissue disorders) 
[1]. Guillain-Barré syndrome (GBS) has been fractionated 
in recent years according to clinical, neurophysiological, 
and pathological characteristics, as acute inflammatory 
demyelinating polyneuropathy, acute motor axonal 
neuropathy, acute motor and sensory axonal neuropathy, and 
Miller Fisher syndrome. These syndromes may be associated 
with various anti-ganglioside antibodies [2]. Involvement 
of nerve roots (radiculopathies) may also contribute to 
symptomatology; for example, there is root involvement in 
GBS (polyradiculoneuropathy).
Neuromuscular junction transmission disorders may 
produce acute flaccid quadriparesis, for example in 
myasthenia gravis, Lambert-Eaton myasthenic syndrome 
(wherein tendon reflexes may be markedly depressed, but 
present with facilitation), and botulism. The presence of 
sensory symptoms in our patient ruled out these diagnoses, 
likewise acute myopathies such as polymyositis that may also 
enter the differential diagnosis of acute flaccid quadriparesis. 
Initial Investigations
Because of the rapidly progressive onset of weakness causing 
the patient to be “off legs”, with bladder involvement, and in 
the absence of preceding pyrexial or gastrointestinal illness, 
the initial investigation was magnetic resonance imaging 
(MRI) of the spinal cord, arranged acutely to exclude 
compressive or inflammatory disease. This proved normal. 
The key investigations to follow were electrodiagnostic studies 
and cerebrospinal fluid (CSF) analysis.
Neurophysiological studies comprising electromyography 
(EMG) and nerve conduction studies were performed. The 
latter showed slowed motor conduction velocities in motor 
nerves (e.g., peroneal 33 m/s, normal >40 m/s), but with 
normal latencies and amplitudes. F wave latencies were absent 
(tibial nerve) or markedly delayed (median, ulnar about 40 
ms, normal <30 ms). Sensory amplitudes were reduced (e.g., 
median 3.4 mV, normal 4–20; sural 2.0 mV, normal 5–40), but 
with normal latencies. EMG showed no acute denervation, 
but discrete motor units were seen in distal muscles, with 
no volitional activity in proximal muscles of the lower limbs. 
These findings were consistent with an acute demyelinating 
polyneuropathy.
Lumbar puncture was undertaken for CSF analysis. CSF 
protein was elevated (1.49 g/l; normal range 0.1–0.45 g/l) with 
normal glucose (3.8 mmol/l; plasma glucose = 6.7 mmol/l). 
CSF cell count showed <5 red cells and 14 white cells (normal 
range <7). Cytology showed these cells to be lymphocytes and 
macrophages, but no neoplastic cells were seen. CSF oligoclonal 
band analysis showed a type 4 pattern with multiple matching 
bands, a finding consistent with systemic inflammation.
Routine blood tests showed normal haematological 
parameters and blood electrolytes. Liver-related enzymes 
(alkaline phosphatase, aspartate transaminase, gamma-
glutamyltransferase) were elevated but with normal bilirubin 
and clotting parameters.
Initial Formulation
In light of the clinical, neurophysiological, and CSF findings, 
a provisional diagnosis of GBS was made, although the 
atypical elevated CSF cell count was noted.
Although possible earlier descriptions of acute 
inflammatory neuropathy by Wardrop (1834) and by 
Landry (1859, “acute ascending paralysis”) exist [3,4], it 
was the paper by Guillain, Barré, and Strohl published in 
1916 that first drew attention to the CSF finding of raised 
protein in the absence of cellular reaction, the dissociation 
albuminocytologique, as characteristic of the condition that 
would subsequently immortalise the first two authors [5].
Initial Treatment
Because of the patient’s urinary retention, the bladder was 
catheterised. Evidence of autonomic involvement elsewhere 
was sought by continuous monitoring of cardiac rhythm. 
Although there was no complaint of breathing difficulty, 
forced vital capacity was monitored to pre-empt respiratory 
insufficiency. Because of immobility, standard prophylaxis for 
deep vein thrombosis was instituted (graduated compression 
stockings, fractionated subcutaneous heparin). 
Evidence-based treatment guidelines for GBS recommend 
either plasma exchange or intravenous immunoglobulin 
(IVIg) as the initial treatment of choice [6]. Since the latter 
was more practical, the patient received a course of IVIg at 1 
g/day for three consecutive days.
Further Formulation and Investigations
Current diagnostic criteria for GBS are based on clinical 
and neurophysiological features [7,8]. Typical CSF findings 
support the diagnosis, although it is recognised that protein 
elevation may not be seen, especially if lumbar puncture is 
performed in the early stages of the disease. Contrary to the 
original findings of Guillain and his colleagues [5], criteria 
do permit cells in the CSF, with a cut-off of 10 mononuclear 
lymphocytes/ml. Increased CSF cell count is recognised 
as occurring if GBS is superimposed on an infection such 
as HIV or Lyme disease. Clinical and investigative features 
of GBS do not seem to differ in young and elderly patients 
[9]. Hence the finding of 14 cells/ml in our patient’s CSF 
was deemed atypical. Furthermore, the type 4 CSF banding 
Box 2: Differential Diagnosis of Acute 
Neuropathies
Primary—Guillain-Barré syndrome variants:
sÈ !CUTEÈINFLAMMATORYÈDEMYELINATINGÈPOLYNEUROPATHY
sÈ !CUTEÈMOTORÈAXONALÈNEUROPATHY
sÈ !CUTEÈMOTORÈANDÈSENSORYÈAXONALÈNEUROPATHYÈ
sÈ -ILLERÈ&ISHERÈSYNDROME
Secondary:
sÈ -ETABOLICÈDIABETESÈURAEMIAÈPORPHYRIA
sÈ )NFECTIONÈ,YMEÈDISEASEÈDIPHTHERIAÈ()6ÈHEPATITISÈ#
sÈ $RUGSTOXINSÈALCOHOLÈORGANOPHOSPHATESÈHEXACARBONSÈHEAVYÈ
metals (arsenic, thallium, gold)
sÈ !UTOIMMUNEÈVASCULITICÈNEUROPATHYÈWITHÈORÈWITHOUTÈ
connective tissue disorder
sÈ -ALIGNANTÈPARANEOPLASIA
sÈ /THERÈCRITICALÈILLNESSÈPOLYNEUROPATHYPLoS Medicine  |  www.plosmedicine.org 1213 August 2008  |  Volume 5  |  Issue 8  |  e180
pattern, also termed the “mirror pattern”, which occurs when 
the oligoclonal pattern in the CSF and serum is essentially 
the same, reflects primarily a systemic disease; or if there is 
infection in the central nervous system such as meningitis, 
the systemic response plays a predominant part. This pattern 
would be unusual for typical GBS.
MRI of the spinal cord is not required in all suspected 
cases of GBS, but may be indicated to exclude myelopathy if 
there are atypical features, as in this case, since the penalty 
for delayed diagnosis of cord compression may be permanent 
neurological disability.
Further investigations in our patient included testing 
for a panel of anti-ganglioside antibodies associated with 
acute neuropathies [2]; these proved negative. Serology 
for infection with Campylobacter jejuni was negative, as 
were investigations for other possible acute infections 
(cytomegalovirus, Epstein-Barr virus, mycoplasma).
Because of the CSF findings and the abnormalities in 
liver-related blood tests, further investigations were deemed 
appropriate. A panel of onconeural antibodies (Hu, Yo, 
Ri, Ma2, amphiphysin, CV2, Tr) was negative. Of tumour 
markers, α- foetoprotein, carcinoembryonic antigen, and 
total human chorionic gonadotropin were normal, but both 
CA125 (45 U/ml; normal 0–21 U/ml), and CA19-9 (521.0 U/
ml; normal 0–25 U/ml), were above the normal range.
The elevated tumour markers prompted further 
investigation to search for an underlying tumour. Computed 
tomographic scanning of the abdomen and pelvis was normal, 
with no lymphadenopathy or organomegaly observed. 
The patient then proceeded to endoscopic retrograde 
cholangiopancreatography, which showed a filling defect in 
the pancreatic duct indicative of pancreatic cancer.
Progress
No neurological improvement was observed following 
treatment with IVIg. The patient developed a chest infection 
and died two weeks later. Permission for autopsy was not 
granted. The family gave consent for the publication of this 
case report.
DISCUSSION
GBS has on occasion been reported in association with 
occult cancer. This might be a chance concurrence of 
two aetiologically distinct disorders, but might also reflect 
a paraneoplastic process. In the current classification of 
paraneoplastic disorders, GBS is regarded as a “non-classic 
syndrome”, since it is not associated with known onconeural 
antibodies. The more typical paraneoplastic syndrome 
of the peripheral nervous system is a subacute sensory 
neuronopathy, often associated with anti-Hu antibodies [10]. 
Nonetheless, one study of a large number of cases of typical 
GBS found the incidence of carcinoma occurring with short 
latency to be 1.7% [11]. GBS has on occasion been reported 
in association with pancreatic cancer [12].  
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Key Learning Points
sÈ !CUTEÈEVOLVINGÈFLACCIDÈQUADRIPARESISÈHASÈAÈBROADÈDIFFERENTIALÈ
diagnosis, encompassing spinal cord, peripheral nerve, 
neuromuscular junction, and muscle disorders.
sÈ !FTERÈCAUSESÈOFÈMYELOPATHYÈAREÈEXCLUDEDÈBYÈSTRUCTURALÈIMAGINGÈ
(MRI), the key diagnostic investigations of acute evolving 
flaccid quadriparesis are neurophysiology (EMG, nerve 
conduction studies) and CSF analysis.
sÈ '"3ÈISÈTHEÈMOSTÈCOMMONÈCAUSEÈOFÈACUTEÈPOLYNEUROPATHYÈ
this diagnosis may be sub-classified based on clinical and 
neurophysiological findings, and presence of anti-ganglioside 
antibodies.
sÈ &EATURESÈhATYPICALvÈFORÈ'"3ÈSUCHÈASÈELEVATEDÈ#3&ÈCELLÈCOUNTÈ
or abnormal liver-related blood tests, should prompt 
consideration of other concurrent diagnoses, including 
underlying malignancy.